Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Revenue
996
986
957
898
821
648
Revenue Growth (YoY)
4%
3%
7%
9%
27%
11%
Cost of Revenue
660
653
634
582
524
422
Gross Profit
335
332
322
316
296
226
Selling, General & Admin
131
129
125
125
110
93
Research & Development
28
27
24
26
23
22
Operating Expenses
145
145
132
145
128
111
Other Non Operating Income (Expenses)
0
-8
-6
-8
0
0
Pretax Income
193
187
183
185
158
123
Income Tax Expense
42
40
33
33
32
22
Net Income
150
146
149
151
125
100
Net Income Growth
13%
-2%
-1%
21%
25%
30%
Shares Outstanding (Diluted)
150.81
150.61
150.61
150.61
150.6
150.6
Shares Change (YoY)
-1%
0%
0%
0%
0%
0%
EPS (Diluted)
1
0.97
0.99
1
0.83
0.67
EPS Growth
13%
-2%
-1%
21%
24%
31%
Free Cash Flow
11
35
79
6
29
33
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
33.63%
33.67%
33.64%
35.18%
36.05%
34.87%
Operating Margin
19.07%
18.86%
19.85%
19.04%
20.46%
17.59%
Profit Margin
15.06%
14.8%
15.56%
16.81%
15.22%
15.43%
Free Cash Flow Margin
1.1%
3.54%
8.25%
0.66%
3.53%
5.09%
EBITDA
272
265
254
217
223
150
EBITDA Margin
27.3%
26.87%
26.54%
24.16%
27.16%
23.14%
D&A For EBITDA
82
79
64
46
55
36
EBIT
190
186
190
171
168
114
EBIT Margin
19.07%
18.86%
19.85%
19.04%
20.46%
17.59%
Effective Tax Rate
21.76%
21.39%
18.03%
17.83%
20.25%
17.88%
Follow-Up Questions
What are AlphaTime Acquisition Corp's key financial statements?
According to the latest financial statement (Form-10K), SCHOTT Pharma AG & Co KgaA has a total asset of $1,598, Net profit of $146
What are the key financial ratios for ATMCW?
SCHOTT Pharma AG & Co KgaA's Current ratio is 2.26, has a Net margin is 14.8, sales per share of $6.54.
How is AlphaTime Acquisition Corp's revenue broken down by segment or geography?
SCHOTT Pharma AG & Co KgaA largest revenue segment is Drug Containment Solutions, at a revenue of 518,355,000 in the most earnings release.For geography, EMEA is the primary market for SCHOTT Pharma AG & Co KgaA, at a revenue of 540,295,000.
Is AlphaTime Acquisition Corp profitable?
yes, according to the latest financial statements, SCHOTT Pharma AG & Co KgaA has a net profit of $146
Does AlphaTime Acquisition Corp have any liabilities?
yes, SCHOTT Pharma AG & Co KgaA has liability of 706
How many outstanding shares for AlphaTime Acquisition Corp?
SCHOTT Pharma AG & Co KgaA has a total outstanding shares of 150.61